Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Spot On Sciences is a private medical device and biospecimen-sampling company focused on remote collection, storage, and shipment of small-volume biological samples. Its core commercial product family, HemaSpot, is a patented dried blood and microsample collection platform designed to improve sample quality, simplify decentralized sampling, and reduce cold-chain and biohazard shipping burdens. The company markets products including HemaSpot HF, HemaSpot HD, and HemaSpot SE for research use and, in some geographies, CE-marked in vitro diagnostic applications. Spot On Sciences has been used in global health, diagnostics, and research settings, including applications related to hepatitis and HIV testing and monitoring. The business appears to operate as a platform/device company rather than a therapeutic drug developer, so it does not have a conventional drug pipeline.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Spot On Sciences.